New Document
Corporate Profile Products Investor Relations News Room Careers Contact Us Manufacturing Quality Assurance Environment, Health & Safety R & D Contract Research & Manufacturing Home
 

Financial Year 2007 - 2008

Quarter IV
(March 2008)

Quarter III
(December 2007)

Quarter II
(September 2007)

Quarter I
(June 2007)

Financial Year 2006 - 2007

Quarter IV
(March 2007)

Quarter III
(December 2006)

Quarter II
(September 2006)

Quarter I
(June 2006)

Financial Year 2005 - 2006

Quarter IV
(March 2006)

Quarter III
(December 2005)

Quarter II
(September 2005)

Quarter I
(June 2005)

Financial Year 2004 - 2005

Quarter IV
(March 2005)

Quarter III
(December 2004)

Quarter II
(September 2004)

Quarter I
(June 2004)

Financial Year 2003 - 2004

Quarter IV
(March 2004)

Quarter III
(December 2003)

Quarter II
(September 2003)

Quarter I
(June 2003)

Financial Year 2002 - 2003

Quarter IV
(March 2003)

Quarter III
(December 2002)

Quarter II
(September 2002)

Quarter I
(June 2002)


AUDITED FINANCIAL RESULTS
FOR
THE QUARTER ENDED 31ST DECEMBER 2002


(Rs.in Million )
Sl. No Particulars Quarter ended 31st December 9 Months ended 31st December Year ended 31st March 2002 (Audited)
2002 (Audited) 2001
(UnAudited)
2002
(Audited)
2001
(UnAudited)
  Gross Sales 787.42 213.16 1897.48 756.69 1038.89
01.
02.
03.




04.
05.
06.
07.
08.
09.
10.
11.
12.
13.

14.
Net Sales
Other Income
Total Expenditure
a) (Increase)/Decrease in Stock
b) Consumption of Raw materials
c) Staff Cost
d) Other Expenditure
Interest
Depreciation
Profit before Tax (1+2-3-4-5)
Provision for Tax
Profit after Tax (6-7)
Provision for Deferred Tax
Income Tax for earlier years
Profit after Tax (8-9-10)
Paid up Equity Share Capital
Reserves excluding revaluation
reserves
Basic E.P.S in Rs.
Diluted E.P.S in Rs.
** (Annualised )
768.34
--
411.88
54.00
196.07
14.01
147.79
14.42
6.01
336.01
15.50
320.51
11.86
0.49
308.16
71.93

--
42.84
--
191.46
--
173.03
0.81
122.36
12.20
37.64
4.17
3.33
10.91
1.90
9.01
--
1.19
7.81
71.87

--
--
--
1835.65
0.76
987.45
59.22
551.86
41.83
334.52
34.50
18.33
796.12
28.00
768.12
15.50
0.49
752.13
71.93

--
104.55
99.13
675.32
1.78
615.87
(27.13)
475.28
32.26
135.46
10.38
8.56
42.28
2.90
39.38
--
1.19
38.18
71.87

--
5.78
--
932.07
1.78
826.35
(74.37)
670.52
49.45
180.75
16.73
15.25
75.51
4.60
70.91
15.70
10.38
44.82
71.93

143.25
**10.83
--
Notes :

  1. The above Audited Financial Results were reviewed in the Audit Committee, approved and taken on record by the Board of Directors at their meeting held on 30th January 2003.
  2. Income tax is computed for nine months on the basis of annualised taxable income for the Asst. year 2003-04 after considering various deductions. Provision for Deffered Tax is computed for 9 months ended 31.12.2002.
  3. Accounting Standard No.17 dealing with Segment Accounting is not applicable as the company is engaged only in the segment of manufacture and sale of bulk drugs.
  4. Consequent to shareholders approval of the Scheme of Amalgamation, petitions have been filed with the respective Hon'ble High Courts for merger of Medicorp Technologies India Limited and Vorin Laboratories Limited into Matrix Laboratories Limited and the Company is awaiting final orders.
  5. The Company has completed aquisition of 33.89% out of the total Equity share capital of Rs.1924.45 lakhs in Medicorp Technologies India Ltd. The Company has also acquired 21% equity from Shriram Group,Chennai and transfer of Equity is under progress.
  6. Pending Final orders of the respective Hon'ble High Courts on merger, the financial results of Vorin Laboratories Ltd and Medicorp Technologies India Ltd have not been taken into account. Similarly impact on EPS has also not been considered.
  7. In pursuance of the resolution passed by the shareholers on 6th November 2002, the company has alloted / proposed to allot in aggregate 25,30,951 Equity shares of Rs.10 each to promoters and their associates on preferential basis and the same has been considered for computation of Diluted EPS.

  For and on behalf of the Board



Place : Secunderabad
Date : 30th January 2003
Sd/-
N.PRASAD

Chairman & Managing Director


Foote Page